Page last updated: 2024-12-07
s 135
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
S 135: GABA receptor agonist; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 113637 |
CHEMBL ID | 3144843 |
MeSH ID | M0164457 |
Synonyms (8)
Synonym |
---|
s 135 |
2-(5-methylthien-3-yl)-2,5-dihydro-3h-pyrazolo(4,3-c)quinolin-3-one |
3h-pyrazolo(4,3-c)quinolin-3-one, 2,5-dihydro-2-(5-methyl-3-thienyl)- |
104679-67-6 |
CHEMBL3144843 |
2-(5-methylthiophen-3-yl)-2,5-dihydro-3h-pyrazolo[4,3-c]quinolin-3-one |
2-(5-methylthiophen-3-yl)-1,2-dihydro-3h-pyrazolo[4,3-c]quinolin-3-one |
DTXSID20909122 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (9)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID40967 | Binding affinity against benzodiazepine (BZ) receptor by displacing [3H]diazepam in cerebral cortex of Wistar rats | 1988 | Journal of medicinal chemistry, Sep, Volume: 31, Issue:9 | Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors. |
AID348954 | Displacement of [3H]diazepam from GABAA/BzR in rat brain membrane | 2008 | European journal of medicinal chemistry, Jul, Volume: 43, Issue:7 | Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor. |
AID110217 | Ability to inhibit pentylenetetrazole (PTZ) induced convulsions in mice after peroral administration at 75 mg/Kg; Range is between (0.47-0.94) | 1987 | Journal of medicinal chemistry, Mar, Volume: 30, Issue:3 | A new thienylpyrazoloquinoline: a potent and orally active inverse agonist to benzodiazepine receptors. |
AID39938 | Displacement of [3H]diazepam from rat cerebral cortex benzodiazepine receptor | 1996 | Journal of medicinal chemistry, Jul-05, Volume: 39, Issue:14 | Synthesis and structure--activity relationships of fused imidazopyridines: a new series of benzodiazepine receptor ligands. |
AID131056 | Inverse agonist activity of orally administered compound against a subcutaneous dose of 75 mg/kg of PTZ-induced convulsions in mice | 1988 | Journal of medicinal chemistry, Sep, Volume: 31, Issue:9 | Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors. |
AID110218 | Ability to inhibit pentylenetetrazole (PTZ) induced convulsions in mice after peroral administration at 90 mg/Kg | 1987 | Journal of medicinal chemistry, Mar, Volume: 30, Issue:3 | A new thienylpyrazoloquinoline: a potent and orally active inverse agonist to benzodiazepine receptors. |
AID131059 | Inverse agonist activity of orally administered compound against a subcutaneous dose of 90 mg/kg of PTZ-induced convulsions in mice | 1988 | Journal of medicinal chemistry, Sep, Volume: 31, Issue:9 | Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors. |
AID40966 | Displacement of [3H]-diazepam from GABA-A benzodiazepine receptor of rat cerebral cortex | 1987 | Journal of medicinal chemistry, Mar, Volume: 30, Issue:3 | A new thienylpyrazoloquinoline: a potent and orally active inverse agonist to benzodiazepine receptors. |
AID493017 | Wombat Data for BeliefDocking | 2002 | European journal of medicinal chemistry, Mar, Volume: 37, Issue:3 | Local intersection volume: a new 3D descriptor applied to develop a 3D-QSAR pharmacophore model for benzodiazepine receptor ligands. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 50.29
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (50.29) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |